Stakeholder Engagement In A Comparative Effectiveness/Implementation Study To Prevent S. aureus Infection Recurrence: CA-MRSA Project (CAMP2)

Online Publication Date:
October 6, 2021
Publication Status:
Published
Published Article MUSE Link:
Manuscript PDF File:

**Published in Progress in Community Health Partnerships (PCHP) volume 16. All rights reserved.**

ABSTRACT
Background: Methicillin-Resistant (MRSA) or Methicillin-Sensitive (MSSA) Staphylococcus aureus skin and soft tissue infections (SSTIs) pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination.
Objectives: This trial implemented infection prevention protocols in homes via Community Health Workers/Promotoras.
Methods
We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New-York-based Federally Qualified Health Centers and community hospital Emergency Departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in-person and remotely for shared decision-making and trial oversight.
Results: The intervention trial consented participants with SSTIs from MRSA or MSSA, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months.
Lessons Learned: The retention of the CPSAC during the trial demonstrated high levels of engagement.
Conclusions: CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges.